<?xml version="1.0" encoding="UTF-8"?>
<p>Taken together, current evidence strongly supports a paradigm shift in the diagnosis of PD with a new focus on defining prodromal stages of the disease. In fact, a task force of the International Parkinson and Movement Disorder Society (MDS) has very recently developed research criteria for the definition of prodromal PD by combining various risk and prodromal markers [
 <xref rid="r153" ref-type="bibr">153</xref>] with the ultimate goal of designing clinical trials to test interventions for disease prevention in at-risk individuals.
</p>
